SHH and medulloblastoma: Furthermore, inappropriate activation of Shh expression (67, 71, 72) or Hh signaling (73–75) has been implicated in overproliferation phenotypes in diseases such as the Gorlin syndrome, basal cell carcinoma, and medulloblastoma.